Somatic and germline RET mutations leading to constitutive RET activation are also found in cancers, including multiple endocrine neoplasia type 2 A and 2B (MEN2A and MEN2B) syndromes and familial medullary thyroid carcinoma (MTC)14,15. This evidence concerns the gene RET and multiple endocrine neoplasia type 2.